chr6-32038482-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000500.9(CYP21A2):āc.60G>Cā(p.Trp20Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,587,140 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 32)
Exomes š: 0.000029 ( 0 hom. )
Consequence
CYP21A2
NM_000500.9 missense
NM_000500.9 missense
Scores
1
11
5
Clinical Significance
Conservation
PhyloP100: 3.17
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP21A2 | NM_000500.9 | c.60G>C | p.Trp20Cys | missense_variant | 1/10 | ENST00000644719.2 | NP_000491.4 | |
CYP21A2 | NM_001128590.4 | c.60G>C | p.Trp20Cys | missense_variant | 1/9 | NP_001122062.3 | ||
CYP21A2 | NM_001368143.2 | c.-365G>C | 5_prime_UTR_variant | 1/10 | NP_001355072.1 | |||
CYP21A2 | NM_001368144.2 | c.-275G>C | 5_prime_UTR_variant | 1/9 | NP_001355073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP21A2 | ENST00000644719.2 | c.60G>C | p.Trp20Cys | missense_variant | 1/10 | NM_000500.9 | ENSP00000496625.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152106Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
25
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000980 AC: 20AN: 204022Hom.: 0 AF XY: 0.0000718 AC XY: 8AN XY: 111458
GnomAD3 exomes
AF:
AC:
20
AN:
204022
Hom.:
AF XY:
AC XY:
8
AN XY:
111458
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000293 AC: 42AN: 1435034Hom.: 0 Cov.: 104 AF XY: 0.0000281 AC XY: 20AN XY: 711674
GnomAD4 exome
AF:
AC:
42
AN:
1435034
Hom.:
Cov.:
104
AF XY:
AC XY:
20
AN XY:
711674
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74288
GnomAD4 genome
AF:
AC:
25
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 19, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T;T;.;.
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D;D;.
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;D;.
Sift4G
Uncertain
D;.;D;D;D;.
Polyphen
D;D;.;.;.;D
Vest4
MutPred
Loss of catalytic residue at L18 (P = 0.0039);Loss of catalytic residue at L18 (P = 0.0039);Loss of catalytic residue at L18 (P = 0.0039);Loss of catalytic residue at L18 (P = 0.0039);Loss of catalytic residue at L18 (P = 0.0039);Loss of catalytic residue at L18 (P = 0.0039);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at